King's College London

Research portal

Protein status in phenylketonuria: A scoping review

Research output: Contribution to journalArticlepeer-review

Sarah J. Firman, Radha Ramachandran, Kevin Whelan, Oliver C. Witard, Majella O'Keeffe

Original languageEnglish
Pages (from-to)894-922
Number of pages29
JournalCLINICAL NUTRITION
Volume41
Issue number4
Early online date18 Feb 2022
DOIs
Accepted/In press14 Feb 2022
E-pub ahead of print18 Feb 2022
PublishedApr 2022

Bibliographical note

Funding Information: Sarah Firman is funded by Health Education England/National Institute for Health Research ( NIHR300395 ). This review presents independent research funded by the HEE/NIHR. The views expressed are those of the author(s) and not necessarily those of HEE, the NHS, the NIHR or the Department of Health and Social Care. Funding Information: Sarah Firman is funded by Health Education England/National Institute for Health Research (NIHR300395). This review presents independent research funded by the HEE/NIHR. The views expressed are those of the author(s) and not necessarily those of HEE, the NHS, the NIHR or the Department of Health and Social Care.Sarah Firman has received funding to attend conferences and study days from Nutricia, Vitaflo International and Dr. Sch?r UK Ltd, and consulting fees from Vitaflo International and Meta Healthcare Ltd. Kevin Whelan is in receipt of research funding from Danone and has acted as a consultant for Danone. Publisher Copyright: © 2022 The Author(s)

Documents

King's Authors

Abstract

Background & aims: The physical and functional outcomes of lifelong treatment with a phenylalanine restricted diet for the management of Phenylketonuria (PKU) remain unknown. Given that the mainstay of dietary management consists of modifying the sources of ingested protein, various aspects of body protein status could be compromised. Objectives: To examine the existing evidence regarding the protein status of people with PKU and identify nutritional and lifestyle variables that influence protein status. Eligibility criteria: Studies reporting anthropometric, biochemical and/or functional measurements of body protein status in people with PKU were eligible. Source of evidence: MEDLINE (Ovid), Embase (Ovid), CENTRAL, Web of Science and Scopus, and conference abstracts. Results: Seventy studies were included in the review. The majority of studies assessing protein status based on anthropometric measurements observed no differences between people with PKU and controls, although deficits in muscle mass were reported within PKU cohorts. Findings for biochemical assessment of protein status were mixed and limited studies assessed protein status using functional measures. Factors such as participant age, sex, metabolic control, protein source, type of protein substitute, and pharmacological treatments were found to modulate protein status of people with PKU. Conclusions: Findings were inconclusive regarding body protein status in people with PKU. The relationship between diet and protein status outcomes remains unclear and further research is warranted to determine the impact of dietary regimens on physical and functional outcomes, and to understand the best clinical assessments to reliably monitor the protein status in people with PKU.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454